# Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema

> **NCT06873087** · PHASE4 · COMPLETED · sponsor: **SB Istanbul Education and Research Hospital** · enrollment: 30 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** İsotretinoin

## Key facts

- **NCT ID:** NCT06873087
- **Lead sponsor:** SB Istanbul Education and Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-01
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06873087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06873087, "Changes in PACAP, CGRP, and VIP Levels in Rosacea Patients on Systemic Isotretinoin and Their Association with Erythema". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06873087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*